199 related articles for article (PubMed ID: 9331147)
1. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus.
Fass R; Yalam JM; Camargo L; Johnson C; Garewal HS; Sampliner RE
Dig Dis Sci; 1997 Sep; 42(9):1853-8. PubMed ID: 9331147
[TBL] [Abstract][Full Text] [Related]
2. Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium.
Grade A; Pulliam G; Johnson C; Garewal H; Sampliner RE; Fass R
Am J Gastroenterol; 1997 Nov; 92(11):2040-3. PubMed ID: 9362188
[TBL] [Abstract][Full Text] [Related]
3. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results.
Sampliner RE; Fennerty B; Garewal HS
Gastrointest Endosc; 1996 Nov; 44(5):532-5. PubMed ID: 8934157
[TBL] [Abstract][Full Text] [Related]
4. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
Stein HJ; Kauer WK; Feussner H; Siewert JR
J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
[TBL] [Abstract][Full Text] [Related]
5. Esophageal acid sensitivity in Barrett's esophagus.
Johnson DA; Winters C; Spurling TJ; Chobanian SJ; Cattau EL
J Clin Gastroenterol; 1987 Feb; 9(1):23-7. PubMed ID: 3559107
[TBL] [Abstract][Full Text] [Related]
6. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.
Dulai GS; Jensen DM; Cortina G; Fontana L; Ippoliti A
Gastrointest Endosc; 2005 Feb; 61(2):232-40. PubMed ID: 15729231
[TBL] [Abstract][Full Text] [Related]
8. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.
Sampliner RE; Faigel D; Fennerty MB; Lieberman D; Ippoliti A; Lewin K; Weinstein WM
Gastrointest Endosc; 2001 May; 53(6):554-8. PubMed ID: 11323578
[TBL] [Abstract][Full Text] [Related]
9. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus.
Sampliner RE; Camargo L; Fass R
Am J Gastroenterol; 2002 Feb; 97(2):270-2. PubMed ID: 11866260
[TBL] [Abstract][Full Text] [Related]
10. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Menges M; Müller M; Zeitz M
Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
[TBL] [Abstract][Full Text] [Related]
11. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus.
Sharma P; Bhattacharyya A; Garewal HS; Sampliner RE
Gastrointest Endosc; 1999 Aug; 50(2):159-64. PubMed ID: 10425406
[TBL] [Abstract][Full Text] [Related]
12. Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor.
Fass R; Sampliner RE; Malagon IB; Hayden CW; Camargo L; Wendel CS; Garewal HS
Aliment Pharmacol Ther; 2000 May; 14(5):597-602. PubMed ID: 10792123
[TBL] [Abstract][Full Text] [Related]
13. The effect of argon plasma coagulation ablation on esophageal motility and chemoreceptor sensitivity in Barrett's esophagus patients.
Smythe A; Elghellal K; Kelty C; Mitton D; Patel K; Ackroyd R
Dis Esophagus; 2010 Aug; 23(6):445-50. PubMed ID: 20236298
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.
Van Laethem JL; Cremer M; Peny MO; Delhaye M; Devière J
Gut; 1998 Dec; 43(6):747-51. PubMed ID: 9824599
[TBL] [Abstract][Full Text] [Related]
15. Patients with Barrett's esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls.
Lottrup C; Krarup AL; Gregersen H; Ejstrud P; Drewes AM
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27891754
[TBL] [Abstract][Full Text] [Related]
16. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
Singh P; Taylor RH; Colin-Jones DG
Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
[TBL] [Abstract][Full Text] [Related]
17. Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus.
Faigel DO; Lieberman DA; Weinstein WM; Fanning S; Fennerty MB; Sampliner RB
Gastrointest Endosc; 2002 Jan; 55(1):23-6. PubMed ID: 11756909
[TBL] [Abstract][Full Text] [Related]
18. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
[TBL] [Abstract][Full Text] [Related]
20. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
